{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T11:39:54Z","timestamp":1780400394660,"version":"3.54.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.neurobiolaging.2023.02.006","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T21:37:31Z","timestamp":1677015451000},"page":"103-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Independent role of Alzheimer's disease genetics and C-reactive protein on cognitive ability in aging"],"prefix":"10.1016","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7532-4665","authenticated-orcid":false,"given":"Adil","family":"Supiyev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzhang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"H\u00e4gg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Kauppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0001","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41582-021-00549-x","article-title":"Peripheral and central immune system crosstalk in Alzheimer disease \u2014 a research prospectus","volume":"17","author":"Bettcher","year":"2021","journal-title":"Nat. Rev. Neurol"},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0002","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0003","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s12603-011-0340-x","article-title":"Sex differences in the association between muscle quality, inflammatory markers, and cognitive decline","volume":"15","author":"Canon","year":"2011","journal-title":"J. Nutr. Health. Aging."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0004","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/gepi.22339","article-title":"A principal component approach to improve association testing with polygenic risk scores","volume":"44","author":"Coombes","year":"2020","journal-title":"Genet. Epidemiol."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0005","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3233\/JAD-160195","article-title":"Pathway-specific polygenic risk scores as predictors of amyloid-deposition and cognitive function in a sample at increased risk for Alzheimer's Disease","volume":"55","author":"Darst","year":"2017","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0006","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/archneur.61.5.668","article-title":"Inflammatory proteins in plasma and the risk of dementia: the rotterdam study","volume":"61","author":"Engelhart","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0007","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fnagi.2019.00056","article-title":"A review and hypothesized model of the mechanisms that underpin the relationship between inflammation and cognition in the elderly","volume":"11","author":"Fard","year":"2019","journal-title":"Front. Aging. Neurosci"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2023.02.006_bib0008","doi-asserted-by":"crossref","first-page":"e0231627","DOI":"10.1371\/journal.pone.0231627","article-title":"Reliability and validity of the UK Biobank cognitive tests","volume":"15","author":"Fawns-Ritchie","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0009","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/JAD-200578","article-title":"The Differential influence of immune, endocytotic, and lipid metabolism genes on amyloid deposition and neurodegeneration in subjects at risk of Alzheimer's disease","volume":"79","author":"Femminella","year":"2021","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0010","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","article-title":"Inflammaging: a new immune-metabolic viewpoint for age-related diseases","volume":"14","author":"Franceschi","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0011","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41583-021-00533-w","article-title":"The probabilistic model of Alzheimer disease: the amyloid hypothesis revised","volume":"23","author":"Frisoni","year":"2022","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0012","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","article-title":"Role of genes and environments for explaining Alzheimer disease","volume":"63","author":"Gatz","year":"2006","journal-title":"Arch. Gen. Psychiatry."},{"issue":"51","key":"10.1016\/j.neurobiolaging.2023.02.006_bib0013","article-title":"Inflammaging as a prodrome to Alzheimer's disease","volume":"5","author":"Giunta","year":"2008","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2023.02.006_bib0013a","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1017\/S1355617722000108","article-title":"Alzheimer's Disease Polygenic Scores Predict Changes in Episodic Memory and Executive Function Across 12 Years in Late Middle Age","volume":"29","author":"Gustavson","year":"2023","journal-title":"J. Int. Neuropsychol Soc."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0014","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1038\/mp.2015.225","article-title":"Shared genetic aetiology between cognitive functions and physical and mental health in UK Biobank (N=112\u2009151) and 24 GWAS consortia","volume":"21","author":"Hagenaars","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0015","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ebiom.2019.03.051","article-title":"A biologically-informed polygenic score identifies endophenotypes and clinical conditions associated with the insulin receptor function on specific brain regions","volume":"42","author":"Hari Dass","year":"2019","journal-title":"EBioMedicine."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0016","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3233\/JAD-131058","article-title":"Polygenic risk for Alzheimer's disease is not associated with cognitive ability or cognitive aging in non-demented older people","volume":"39","author":"Harris","year":"2014","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0017","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3233\/JAD-2009-1163","article-title":"Impact of APOE on the Healthy Aging Brain: A Voxel-Based MRI and DTI Study","volume":"18","author":"Honea","year":"2009","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0018","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41398-020-00934-y","article-title":"Effects of polygenic risk for Alzheimer's disease on rate of cognitive decline in normal aging","volume":"10","author":"Kauppi","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-021-01649-4","article-title":"Sex-specific effects of polygenic risk for schizophrenia on lifespan cognitive functioning in healthy individuals","volume":"11","author":"Koch","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-99310-z","article-title":"Genetic effects on longitudinal cognitive decline during the early stages of Alzheimer's disease","volume":"11","author":"Kumar","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0021","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","article-title":"Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing","volume":"51","author":"Kunkle","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-24082-z","article-title":"Identifying individuals with high risk of Alzheimer's disease using polygenic risk scores","volume":"12","author":"Leonenko","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0023","doi-asserted-by":"crossref","first-page":"7397","DOI":"10.1007\/s00018-021-03986-5","article-title":"Genomics of Alzheimer's disease implicates the innate and adaptive immune systems","volume":"78","author":"Li","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0024","doi-asserted-by":"crossref","first-page":"243.e1","DOI":"10.1016\/j.neurobiolaging.2019.02.022","article-title":"Identification of genetic heterogeneity of Alzheimer's disease across age","volume":"84","author":"Lo","year":"2019","journal-title":"Neurobiol. Aging."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0025","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.3389\/fimmu.2018.01302","article-title":"The clinical significance and potential role of C-reactive protein in chronic inflammatory and neurodegenerative diseases","volume":"9","author":"Luan","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0026","article-title":"Cognitive test scores in UK Biobank: data reduction in 480,416 participants and longitudinal stability in 20,346 participants","volume":"11","author":"Lyall","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0027","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/acn3.639","article-title":"Decreased plasma C-reactive protein levels in APOE \u03b54 allele carriers","volume":"5","author":"Martiskainen","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0028","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1192\/j.eurpsy.2021.6","article-title":"The association between C-reactive protein, mood disorder, and cognitive function in UK Biobank","volume":"64","author":"Milton","year":"2021","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0029","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline","volume":"581","author":"Montagne","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0030","doi-asserted-by":"crossref","first-page":"e23890","DOI":"10.1371\/journal.pone.0023890","article-title":"C-Reactive Protein and Genetic Variants and Cognitive Decline in Old Age: The PROSPER Study","volume":"6","author":"Mooijaart","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0031","first-page":"e12142","article-title":"Polygenic risk scores for Alzheimer's disease are related to dementia risk in APOE \u025b4 negatives","volume":"13","author":"Najar","year":"2021","journal-title":"Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0032","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0891988709351832","article-title":"Decreased C-reactive protein levels in Alzheimer disease","volume":"23","author":"O'Bryant","year":"2010","journal-title":"J. Geriatr. Psychiatry. Neurol."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0033","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/nar\/gkl842","article-title":"NCBI reference sequences (RefSeq): A curated non-redundant sequence database of genomes, transcripts and proteins","volume":"35","author":"Pruitt","year":"2007","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0034","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK\u00a0: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"Purcell","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0035","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nature08185","article-title":"Common polygenic variation contributes to risk of schizophrenia and bipolar disorder","volume":"460","author":"Purcell","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0036","doi-asserted-by":"crossref","first-page":"e512","DOI":"10.1212\/NXG.0000000000000512","article-title":"Late-onset vs nonmendelian early-onset Alzheimer disease: A distinction without a difference?","volume":"6","author":"Reitz","year":"2020","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0037","article-title":"C-reactive protein and risk of cognitive decline: The REGARDS study","volume":"15","author":"Renter\u00eda","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0038","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1038\/s41380-019-0372-x","article-title":"Polygenic predictors of age-related decline in cognitive ability","volume":"25","author":"Ritchie","year":"2020","journal-title":"Mol. Psychiatry."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0039","first-page":"1","article-title":"Genetic analysis of over half a million people characterises C-reactive protein loci","volume":"13","author":"Said","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101422","article-title":"Immunosenescence and inflammaging in the aging process: age-related diseases or longevity?","volume":"71","author":"Santoro","year":"2021","journal-title":"Ageing. Res. Rev"},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0041","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer's disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0042","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.10265","article-title":"Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study","volume":"52","author":"Schmidt","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0043","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/jnnp-2018-319148","article-title":"Inflammatory markers in Alzheimer's disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies","volume":"90","author":"Shen","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0044","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41593-020-0599-5","article-title":"The multiplex model of the genetics of Alzheimer's disease","volume":"23","author":"Sims","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0045","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/gerona\/glab030","article-title":"A Non-APOE Polygenic Risk Score for Alzheimer's Disease Is Associated With Cerebrospinal Fluid Neurofilament Light in a Representative Sample of Cognitively Unimpaired 70-Year Olds","volume":"76","author":"Skoog","year":"2021","journal-title":"J. Gerontol. A."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0046","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0047","first-page":"68","article-title":"A global reference for human genetic variation","volume":"526","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0048","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bbi.2021.12.008","article-title":"Associations of circulating C-reactive proteins, APOE \u03b54, and brain markers for Alzheimer's disease in healthy samples across the lifespan","volume":"100","author":"Wang","year":"2022","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0049","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000442585","article-title":"Elevated C-reactive protein is associated with cognitive decline in outpatients of a general hospital: the project in sado for total health (PROST)","volume":"6","author":"Watanabe","year":"2016","journal-title":"Dement. Geriatr. Cogn. Dis. Extra."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2020.110986","article-title":"Sex-specific associations of inflammation markers with cognitive decline","volume":"138","author":"West","year":"2020","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0051","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1101\/gr.6665407","article-title":"Prediction of individual genetic risk to disease from genome-wide association studies","volume":"17","author":"Wray","year":"2007","journal-title":"Genome. Res."},{"key":"10.1016\/j.neurobiolaging.2023.02.006_bib0052","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1017\/S0033291717003130","article-title":"High-sensitivity C-reactive protein and cognitive decline: The English longitudinal study of ageing","volume":"48","author":"Zheng","year":"2018","journal-title":"Psychol. Med."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458023000398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458023000398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:45:21Z","timestamp":1759319121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458023000398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":53,"alternative-id":["S0197458023000398"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2023.02.006","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Independent role of Alzheimer's disease genetics and C-reactive protein on cognitive ability in aging","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2023.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}